Natal'Ya Ivanovna Mironyuk

Natal'Ya Ivanovna Mironyuk

Auto-generated profile, based on publicly available information

Natal'Ya Ivanovna Mironyuk

Regional Clinical Hospital of the Kaliningrad Region

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Doklady Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
MVM. A. Vasilenko
M. A. Vasilenko
EKElena Kirienkova
Elena Kirienkova
Daria Shunkina (Skuratovskaia)Daria Shunkina (Skuratovskaia)
Daria Shunkina (Skuratovskaia)
PZP. A. Zatolokin
P. A. Zatolokin
NMN. I. Mironyuk
N. I. Mironyuk
LLLarisa Litvinova
Larisa Litvinova
We investigated the tissue-specific features of the production of adipokines (leptin and adipsin) by adipose tissue in obese patients depending on the degree of obesity and the state of carbohydrate metabolism. An increase in the content of adipsin and leptin in the blood plasma was found. In patients with varying degrees of obesity with and without type 2 diabetes mellitus (DM 2), we determined the level of tissue-specific expression of LEP and CFD genes encoding leptin and adipsin, respectively. The contribution of different adipose tissue depots to the blood plasma level of adipsin and leptin in obese patients with and without DM 2 was established. The disturbance of reciprocal relationships between adipsin and leptin in obesity is associated with the development of insulin resistance.

14 June 2014 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
LLLarisa Litvinova
Larisa Litvinova
MVMariya Aleksandrovna Vasilenko
Mariya Aleksandrovna Vasilenko
PZPavel Anatol'EVich Zatolokin
Pavel Anatol'EVich Zatolokin
NANatal'Ya Nikolaevna Aksenova
Natal'Ya Nikolaevna Aksenova
NFNikolay Sergeevich Fattakhov
Nikolay Sergeevich Fattakhov
EKElena Kirienkova
Elena Kirienkova
Bariatric surgery serves as a model for the assessment of the relationship between body mass index (BMI) reduction and changes in adipokine production and for exploring the endocrine function of the pancreas in patients who do not have the proximal part of the small intestine. Aim. of the study was to assess the biochemical parameters and plasma levels of adipokines [adiponectin, adipsin, leptin, plasminogen activator inhibitor (PAI-1), resistin and visfatin], insulin, C-peptide, ghrelin and incretins [glucose insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)] in patients with morbid obesity after surgery (gastric bypass) and therapeutic correction. Materials and methods. A total of 75 patients (34 men and 41 women; age range: 24?67 years) diagnosed as obese were divided into two groups according to the treatment they received. Biochemical analysis was performed to estimate carbohydrate and lipid metabolism rates and plasma levels of adipokines (adiponectin, adipsin, leptin, PAI-1, resistin, visfatin), insulin, C-peptide, ghrelin and incretins (GIP and GLP-1) using the flow fluorometry. Results. Surgical treatment of obesity resulted in a significant decrease in BMI (from 45.67?9.87 to 32.45?5.35 kg/m2, p

30 March 2017 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
NFNikolai Fattakhov
Nikolai Fattakhov
Daria Shunkina (Skuratovskaia)Daria Shunkina (Skuratovskaia)
Daria Shunkina (Skuratovskaia)
MVM. A. Vasilenko
M. A. Vasilenko
EKElena Kirienkova
Elena Kirienkova
PZP. A. Zatolokin
P. A. Zatolokin
LLLarisa Litvinova
Larisa Litvinova

2 December 2016 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
Daria Shunkina (Skuratovskaia)Daria Shunkina (Skuratovskaia)
Daria Shunkina (Skuratovskaia)
MVMaria A. Vasilenko
Maria A. Vasilenko
NFNikolai Fattakhov
Nikolai Fattakhov
EKElena Kirienkova
Elena Kirienkova
NMNatalia I. Mironyuk
Natalia I. Mironyuk
LLLarisa Litvinova
Larisa Litvinova
Aim. To investigate the association of the GIPR gene polymorphisms rs2302382 and rs8111428 with increased risk of type 2 diabetes mellitus and abdominal obesity.Materials and methods. The study involved 163 patients with abdominal obesity (BMI, 39.5 ± 8.3 kg/m2; age, 44.7 ± 8.9 years; men, 61; women, 102), 72 with type 2 diabetes mellitus (BMI, 43.70 ± 9.32 kg/m2; age, 46.5 ± 10.1 years; men, 29; women, 43) and 91 patients without carbohydrate metabolism disorders (BMI, 36.13 ± 6.72 kg/m2; age, 43.93 ± 8.35 years; men, 32; women 59). The control group comprised 109 relatively healthy volunteers (BMI, 22.6 ± 2.7 kg/m2; age, 39.5 ± 7.6 years; men, 66; women, 43). Genotypes were analysed by real-time PCR and serum insulin and C-peptide levels were evaluated by ELISA.Results. The AA genotype in the rs2302382 polymorphism of GIPR was associated with an increased risk for type 2 diabetes mellitus in abdominal obesity and the CA genotype was associated with a reduced risk. In individuals with abdominal obesity and type 2 diabetes mellitus carrying the CA genotype in rs2302382 polymorphism of GIPR, serum insulin and C-peptide levels were elevated to 56.27 mU/L (55.49–58.41 mU/L) and 2.04 ng/ml (1.37–2.85 ng/ml), respectively (p 0.05). In obese patients with the same genotype and without type 2 diabetes, serum insulin levels and C-peptide levels were 22.73 mU/L (19.07–25.76 mU/L) and 0.73 ng/ml (0.53–1.03 ng/ml), respectively (p 0.05). The GIPR rs8111428 polymorphism was not associated with increased risk of type 2 diabetes mellitus in obesity for any of the groups examined.Conclusion. Serum insulin and C-peptide levels were increased in patients with abdominal obesity who were carriers of the CA genotype in the rs2302382 polymorphism of GIPR, which is associated with a decreased risk of type 2 diabetes mellitus in obesity compared with the CC genotype.

1 November 2017 in Biomeditsinskaya Khimiya
Verified
Journal Article
Closed access
MVM.A. Vasilenko
M.A. Vasilenko
EKElena Kirienkova
Elena Kirienkova
DSD.A. Skuratovskaya
D.A. Skuratovskaya
PZP.A. Zatolokin
P.A. Zatolokin
NMN.I. Mironyuk
N.I. Mironyuk
LLLarisa Litvinova
Larisa Litvinova
Chemerin is a mediator of adipose tissue involved in the regulation of many processes, including lipogenesis, and inflammatory response. The role of chemerin in the development of insulin resistance has been insufficiently studied and needs detailed understanding. The aim of the study was to investigate chemerin production in obese patients with different states of carbohydrate metabolism. The study included 155 patients with a diagnosis of obesity; 34 patients with overweight. The control group 1 consisted of 43 conditionally healthy donors who did not have obesity. For comparison of the results of a study to determine the levels of tissue-specific mRNA expression of the genes IL-6, TNF-a, RARRES2, (encoding IL-6, TNF-a and chemerin) in adipose tissue introduced a control group 2 – 30 patients without obesity. Study on the relative level of mRNA expression of the genes IL-6, TNF-a and RARRES2 (encoding IL-6, TNF-a and chemerin) was carried out using real time PCR. Concentrations of IL-6, TNF-a, and chemerin were measured in serum/plasma using an enzyme-linked immunosorbent assay (ELISA). We found significant differences in the plasma level of chemerin and tissue-specific features of RARRES2 gene expression in obese patients, depending on the degree of obesity and the state of carbohydrate metabolism. Multidirectional associations of RARRES2 gene expression with TNF-a and IL-6 genes in adipose tissues of different localization are shown: in obese patients (BMI £40 kg/m2) without type 2 diabetes – negative, and type 2 diabetes – positive. Identified relationship chemerin plasma content and the expression level of its gene in biopsies with various parameters of carbohydrate and lipid metabolism, proinflammatory molecules indicate chemerin involved in metabolic and immune processes in obesity.

1 March 2018 in Biomeditsinskaya Khimiya
Verified
Journal Article
Closed access
Daria Shunkina (Skuratovskaia)Daria Shunkina (Skuratovskaia)
Daria Shunkina (Skuratovskaia)
MVMaria Vulf
Maria Vulf
EKE.V. Kirienkova
E.V. Kirienkova
NMN.I. Mironyuk
N.I. Mironyuk
PZP.A. Zatolokin
P.A. Zatolokin
LLLarisa Litvinova
Larisa Litvinova
The relationship between the rs2302382, rs8111428 and Glu354Gln (rs1800437) polymorphisms in GIPR (glucosedependent insulinotropic polypeptide receptor) gene and plasma levels of mediators involved in the regulation of carbohydrate metabolism in obese patients with type 2 diabetes (before and after a test breakfast) was investigated. The contribution of polymorphic variants of rs2302382, rs8111428 in GIPR gene in the predisposition to type 2 diabetes in individuals belonging to the Slavic population of Russia was found. Polymorphisms rs2302382 and rs8111428 in the GIPR gene were characterized by the nonequilibrium cohesion. The decrease in the level of expression of the GIPR gene in adipose tissue of the small intestine mesentery in the carriers of the CC genotype rs2302382 and AA rs8111428 was associated with the increase in the plasma leptin level, whereas during normal expression, the plasma content of insulin, and GIP (in persons with the genotype of the polymorphism rs2302382 and AG polymorphism rs8111428), resistin and ghrelin (in individuals with the genotype of the polymorphism rs2302382) increased. We propose the stimulating effect of GIP on the secretion of resistin, leptin and ghrelin, with an increase in insulin production in obese patients with type 2 diabetes.